266 related articles for article (PubMed ID: 21671471)
1. B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
Tekle C; Nygren MK; Chen YW; Dybsjord I; Nesland JM; Maelandsmo GM; Fodstad O
Int J Cancer; 2012 May; 130(10):2282-90. PubMed ID: 21671471
[TBL] [Abstract][Full Text] [Related]
2. B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.
Wang J; Chong KK; Nakamura Y; Nguyen L; Huang SK; Kuo C; Zhang W; Yu H; Morton DL; Hoon DS
J Invest Dermatol; 2013 Aug; 133(8):2050-8. PubMed ID: 23474948
[TBL] [Abstract][Full Text] [Related]
3. B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response.
Quandt D; Fiedler E; Boettcher D; Marsch WCh; Seliger B
Clin Cancer Res; 2011 May; 17(10):3100-11. PubMed ID: 21378130
[TBL] [Abstract][Full Text] [Related]
4. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells.
Flem-Karlsen K; Tekle C; Andersson Y; Flatmark K; Fodstad Ø; Nunes-Xavier CE
Pigment Cell Melanoma Res; 2017 Sep; 30(5):467-476. PubMed ID: 28513992
[TBL] [Abstract][Full Text] [Related]
6. [B7-H3 silencing inhibits human hematological malignancy xenograft tumor tumorigenesis and metastasis in nude mice].
Yan XX; Zhang W; Wang J; Ke XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):286-294. PubMed ID: 28416840
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
8. B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity.
Zhang W; Wang Y; Wang J; Dong F; Zhu M; Wan W; Li H; Wu F; Yan X; Ke X
Int J Oncol; 2015; 46(6):2562-72. PubMed ID: 25872657
[TBL] [Abstract][Full Text] [Related]
9. B7-H3 overexpression in pancreatic cancer promotes tumor progression.
Zhao X; Li DC; Zhu XG; Gan WJ; Li Z; Xiong F; Zhang ZX; Zhang GB; Zhang XG; Zhao H
Int J Mol Med; 2013 Feb; 31(2):283-91. PubMed ID: 23242015
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.
Lim S; Liu H; Madeira da Silva L; Arora R; Liu Z; Phillips JB; Schmitt DC; Vu T; McClellan S; Lin Y; Lin W; Piazza GA; Fodstad O; Tan M
Cancer Res; 2016 Apr; 76(8):2231-42. PubMed ID: 27197253
[TBL] [Abstract][Full Text] [Related]
11. Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation.
Liu Z; Zhang W; Phillips JB; Arora R; McClellan S; Li J; Kim JH; Sobol RW; Tan M
Oncogene; 2019 Jan; 38(1):88-102. PubMed ID: 30082909
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related protein: potential therapeutic target for melanoma invasion and metastasis.
Huang DC; Yang XF; Ochietti B; Fadhil I; Camirand A; Kremer R
Endocrinology; 2014 Oct; 155(10):3739-49. PubMed ID: 25051432
[TBL] [Abstract][Full Text] [Related]
13. B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer.
Ingebrigtsen VA; Boye K; Tekle C; Nesland JM; Flatmark K; Fodstad O
Int J Cancer; 2012 Dec; 131(11):2528-36. PubMed ID: 22473715
[TBL] [Abstract][Full Text] [Related]
14. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
[TBL] [Abstract][Full Text] [Related]
15. Expression of B7-H3 in cancer tissue during osteosarcoma progression in nude mice.
Yin SJ; Wang WJ; Zhang JY
Genet Mol Res; 2015 Nov; 14(4):14253-61. PubMed ID: 26600483
[TBL] [Abstract][Full Text] [Related]
16. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10.
Liu C; Liu J; Wang J; Liu Y; Zhang F; Lin W; Gao A; Sun M; Wang Y; Sun Y
Mol Med Rep; 2013 Jan; 7(1):134-8. PubMed ID: 23128494
[TBL] [Abstract][Full Text] [Related]
17. Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway.
Xie C; Liu D; Chen Q; Yang C; Wang B; Wu H
Sci Rep; 2016 Jun; 6():27528. PubMed ID: 27273624
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3.
Zhao J; Lei T; Xu C; Li H; Ma W; Yang Y; Fan S; Liu Y
Biochem Biophys Res Commun; 2013 Aug; 438(2):439-44. PubMed ID: 23916610
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.
Emeagi PU; Maenhout S; Dang N; Heirman C; Thielemans K; Breckpot K
Gene Ther; 2013 Nov; 20(11):1085-92. PubMed ID: 23804077
[TBL] [Abstract][Full Text] [Related]
20. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
